Ifp Advisors, Inc Trevena Inc Transaction History

Ifp Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 12, 2022	SELL	$0.57 - $1.29 $11,399 - $25,800	-20,000 Closed	0 $0
Q3 2021 Oct 06, 2021	SELL	$1.11 - $1.7 $37,142 - $56,885	-33,462 Reduced 62.59%	20,000 $25,000
Q1 2021 Apr 30, 2021	SELL	$1.77 - $2.93 $6,195 - $10,255	-3,500 Reduced 6.14%	53,462 $95,000
Q4 2020 Jan 25, 2021	BUY	$2.13 - $3.26 $40,795 - $62,438	19,153 Added 50.66%	56,962 $122,000
Q3 2020 Oct 29, 2020	BUY	$1.53 - $3.13 $24,686 - $50,502	16,135 Added 74.44%	37,809 $114,000
Q2 2020 Aug 05, 2020	BUY	$0.48 - $1.75 $5,603 - $20,429	11,674 Added 116.74%	21,674 $33,000
Q4 2019 Jan 17, 2020	BUY	$0.62 - $1.06 $6,200 - $10,600	10,000 New	10,000 $8,000
Q3 2019 Nov 07, 2019	BUY	$0.81 - $1.06 $0 - $0	0 New	0 $0
Q4 2018 Jan 23, 2019	SELL	$0.39 - $3.47 $1,950 - $17,350	-5,000 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$1.39 - $2.25 $4,170 - $6,750	3,000 Added 150.0%	5,000 $0
Q1 2017 Jun 03, 2019	BUY	N/A	2,000	2,000 $7,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.